| scholarly article | Q13442814 |
| P50 | author | Hye-Sook Kim | Q91938131 |
| P2093 | author name string | Akira Sato | |
| Akiko Hiramoto | |||
| Kazutaka Higaki | |||
| Shin-Ichi Miyoshi | |||
| Yuji Kurosaki | |||
| Kyung-Soo Chang | |||
| Rena Isogawa | |||
| Kazuaki Okada | |||
| P2860 | cites work | Qinghaosu (Artemisinin): The Price of Success | Q21032496 |
| Artemisinin Resistance in Plasmodium falciparum Malaria | Q22061852 | ||
| Evidence of Artemisinin-Resistant Malaria in Western Cambodia | Q22061854 | ||
| Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study | Q24598695 | ||
| The global distribution of clinical episodes of Plasmodium falciparum malaria | Q24599466 | ||
| Identification of an endoplasmic reticulum-resident calcium-binding protein with multiple EF-hand motifs in asexual stages of Plasmodium falciparum | Q27973612 | ||
| Qinghaosu (artemisinin): an antimalarial drug from China | Q34193570 | ||
| Medical need, scientific opportunity and the drive for antimalarial drugs | Q34521004 | ||
| Impact of chrysosplenetin on the pharmacokinetics and anti-malarial efficacy of artemisinin against Plasmodium berghei as well as in vitro CYP450 enzymatic activities in rat liver microsome | Q36246585 | ||
| The threat of artemisinin-resistant malaria | Q37069786 | ||
| Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent | Q37138144 | ||
| Stage specific activity of synthetic antimalarial endoperoxides, N-89 and N-251, against Plasmodium falciparum | Q39269574 | ||
| Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol | Q39556880 | ||
| Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5, 7-pentoxocanes and 1,2,4,5-tetroxanes | Q40941195 | ||
| Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. | Q41696128 | ||
| Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes | Q43655345 | ||
| Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug | Q46883171 | ||
| Plasmodium falciparum endoplasmic reticulum-resident calcium binding protein is a possible target of synthetic antimalarial endoperoxides, N-89 and N-251. | Q48022527 | ||
| A pharmacokinetic analysis program (multi) for microcomputer | Q52732710 | ||
| Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study | Q80177342 | ||
| Improvement of Oral Bioavailability of N-251, a Novel Antimalarial Drug, by Increasing Lymphatic Transport with Long-Chain Fatty Acid-Based Self-Nanoemulsifying Drug Delivery System | Q86830674 | ||
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 40 | |
| P577 | publication date | 2019-07-05 | |
| P1433 | published in | Tropical Medicine and Health | Q6158243 |
| P1476 | title | Pharmacokinetic analysis of new synthetic antimalarial N-251 | |
| P478 | volume | 47 |
Search more.